DARPA renews DLT contract with Aethlon
Aethlon Medical (OTCBB:AEMD) says that the Defense Advanced Research Projects Agency (DARPA) has exercised an option agreement to proceed with year-three of a five-year $6.8-million contract under...
View ArticleAethlon readies U.S. study of the Hemopurifier
Aethlon Medical (OTCQB:AEMD), sporting FDA approval of an investigational drug exemption (IDE), plans to begin treating patients infected with hepatitis C virus (HCV) early next year in a feasibility...
View Article
More Pages to Explore .....